Ashraf Eassa
Long/short equity, contrarian, independent research, tech

Emulex: A Product Cycle Play With A Few Interesting Twists

In the world of technology stocks, it is often very lucrative to try to identify a name that is at the very beginning of a product cycle ramp. Unfortunately, this leads to the puzzling paradox that tech stocks often look "cheap" at the top and "expensive" at the bottom. While playing product cycles is usually lucrative, it's even better when the name in question had seen an extra helping of pain due to what should be near-term structural problems. It is my view that Emulex (NYSE:ELX) is a name that offers significant upside on the back of two major upside drivers, coupled with a compelling valuation that serves to limit the downside risk.

Setting The Stage For The...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details